SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-105528
Filing Date
2023-10-02
Accepted
2023-10-02 06:03:13
Documents
13
Period of Report
2023-09-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2326133d5_8k.htm   iXBRL 8-K 27135
2 EXHIBIT 4.1 tm2326133d5_ex4-1.htm EX-4.1 42570
  Complete submission text file 0001104659-23-105528.txt   254243

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA seel-20230930.xsd EX-101.SCH 3015
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE seel-20230930_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE seel-20230930_pre.xml EX-101.PRE 22359
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2326133d5_8k_htm.xml XML 3308
Mailing Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022 (646) 293-2100
SEELOS THERAPEUTICS, INC. (Filer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22245 | Film No.: 231297590
SIC: 2834 Pharmaceutical Preparations